Summary
Uncovering Risks: 45 Chemicals Detected in Pregnant Women Linked to Birth Complications examines the widespread presence of numerous environmental chemicals in pregnant women and their association with adverse birth outcomes. Pregnant individuals are commonly exposed to a complex mixture of substances—including phthalates, organochlorine pesticides (OCPs), polychlorinated biphenyls (PCBs), polybrominated diphenyl ethers (PBDEs), and perfluorinated compounds (PFCs)—many of which persist in the environment despite regulatory restrictions and have been linked to complications such as preterm birth, low birth weight, congenital anomalies, and developmental disorders. These exposures occur through diverse pathways, including diet, consumer products, and environmental contamination, making the cumulative burden a significant public health concern.
Recent biomonitoring studies reveal that pregnant women frequently carry detectable levels of dozens of chemicals simultaneously, with some samples containing as many as 64 distinct compounds. Many of these chemicals function as endocrine-disrupting chemicals (EDCs), interfering with hormonal regulation critical to fetal development, and have been associated with maternal health issues like gestational diabetes and hypertensive disorders. The additive or synergistic effects of combined chemical exposures during pregnancy remain poorly understood, complicating risk assessment and prevention efforts.
Epidemiological and toxicological evidence support links between prenatal exposure to these chemicals and adverse outcomes, including increased risks of preterm delivery, low birth weight, and long-term neurodevelopmental deficits. Notably, chemicals such as di-2-ethylhexylphthalate (DEHP) and perfluorooctanesulfonic acid (PFOS) have been implicated in raising the likelihood of preterm birth and other complications, with disproportionate impacts observed in regions with less stringent regulations, including parts of South Asia, the Middle East, and Africa. Despite bans on some persistent pollutants decades ago, their continued detection highlights ongoing exposure risks and challenges in mitigating harm.
Addressing these risks requires improved regulatory frameworks, enhanced exposure assessment, and public health initiatives aimed at reducing chemical burdens among pregnant populations. While individual behavioral changes, such as choosing phthalate-free products, may help, systemic interventions targeting entire chemical classes are critical to protecting maternal and child health. Ongoing research supported by programs like the Environmental influences on Child Health Outcomes (ECHO) initiative is vital for understanding complex exposure patterns and informing policy to reduce environmentally linked birth complications.
Background
Pregnant women are exposed to a wide array of environmental chemicals, many of which have been linked to adverse perinatal outcomes such as low birthweight, preterm birth, and developmental complications. These chemicals include persistent organic pollutants like polychlorinated biphenyls (PCBs), dichlorodiphenyltrichloroethane (DDT) and its metabolites, and perfluorooctanesulfonic acid (PFOS), which continue to be detected in measurable levels in virtually all pregnant women despite bans and phase-outs in many countries decades ago. Exposure pathways vary depending on the chemical class: for instance, organochlorine pesticides (OCPs) and perfluoroalkyl substances (PFASs) primarily enter the body through diet—via contaminated drinking water, fish, and meat—whereas polybrominated diphenyl ethers (PBDEs) are often absorbed through contact with consumer products such as textiles, furniture, and electronics.
Emerging evidence suggests that many of these compounds act as endocrine-disrupting chemicals, which can interfere with hormonal regulation during fetal development, potentially affecting growth and other developmental outcomes. Additionally, substances like di-2-ethylhexylphthalate (DEHP), a common additive found in cosmetics, detergents, and household products, have been implicated in increasing the risk of preterm births worldwide. Despite growing awareness, the ubiquity and diversity of chemical exposures complicate efforts to fully understand their combined impact on maternal and fetal health.
Research efforts have been constrained by the reliance on targeted analytic chemistry methods, which focus on a limited number of pre-selected chemicals. Typically, only a few hundred compounds are routinely measured in humans, making it challenging to assess the full spectrum of exposures during pregnancy. Non-targeted analysis approaches, however, have begun to reveal a broader range of substances, including endogenous metabolites, exogenous contaminants, pharmaceuticals, and natural products, detected in biological samples from pregnant women.
The health implications of prenatal chemical exposures extend beyond birth outcomes. Associations have been found between these exposures and complications such as gestational diabetes, maternal hypertensive disorders, and longer-term child health effects, including neurodevelopmental issues and increased risks of childhood cancers. Moreover, combined stressors—such as occupational chemical exposure coupled with psychosocial stress—may exacerbate adverse outcomes like reduced birth weight.
Given the persistence of many harmful chemicals in the environment and their presence in everyday products, preventing exposure among pregnant women remains a public health priority. However, this is complicated by the widespread use of these substances in consumer goods and the environment, underscoring the need for improved exposure assessment, regulatory actions, and public awareness to mitigate risks to maternal and fetal health.
Chemicals Detected in Pregnant Women
Recent research has revealed that pregnant women are commonly exposed to a wide array of environmental chemicals, many of which have been linked to adverse birth outcomes such as preterm delivery and low birth weight. A large-scale study analyzing urine samples from over 5,000 women who gave birth between 2000 and 2021 detected an average of 45 different chemicals per sample, with some samples containing as many as 64 distinct compounds. These chemicals originate from various sources including food, drinking water, air pollution, personal care products, fragrances, and household items.
Among the chemicals detected, several classes are of particular concern due to their persistence in the environment and potential health effects. These include phthalates and their replacement plasticizers, polycyclic aromatic hydrocarbons (PAHs), halogenated phenols, organochlorine pesticides (OCPs), polychlorinated biphenyls (PCBs), polybrominated diphenyl ethers (PBDEs), and perfluorinated compounds (PFCs).
Phthalates, synthetic chemicals widely used as plasticizers in personal care products, food packaging, and other consumer goods, are nearly ubiquitous in pregnant women’s samples. Two commonly detected phthalates are Di-2-ethylhexylphthalate (DEHP) and diisononyl phthalate (DiNP). These compounds are known endocrine-disrupting chemicals (EDCs) that can interfere with hormonal regulation critical for healthy pregnancy and fetal development.
Organochlorine pesticides, historically used as insecticides from the 1940s through the 1970s, remain detectable despite being banned or severely restricted decades ago due to their environmental persistence and toxicity. Representative chemicals in this group include dichloro-diphenyl-trichloroethane (DDT), lindane, hexachlorobenzene (HCB), and chlordane. Exposure to these persistent organic pollutants primarily occurs through diet, such as consumption of contaminated water, fish, and meat. Prenatal exposure to OCPs has been associated with severe birth defects and other developmental issues.
Polychlorinated biphenyls (PCBs) and polybrominated diphenyl ethers (PBDEs) are other classes of persistent pollutants found in maternal serum, placental, and fetal tissues. PBDEs are commonly found in consumer products like textiles, furniture, and electronics, leading to widespread human exposure. Perfluorinated compounds (PFCs), another class of synthetic chemicals used in industrial applications, have also been detected in pregnant women and are linked to adverse pregnancy outcomes.
Biomonitoring studies, such as those utilizing data from the National Health and Nutritional Examination Survey (NHANES), have characterized these multiple chemical exposures in pregnant women across various chemical classes. These studies underscore that exposure to multiple chemicals is common, with pregnant women often carrying detectable levels of dozens of chemicals simultaneously.
Given the complex mixture of chemical exposures and their potential additive or synergistic effects on fetal development and birth outcomes, researchers emphasize the need for enhanced regulatory measures and further investigation into combined chemical exposures during pregnancy. The findings highlight the urgent requirement for governments and industries to reduce harmful chemical presence in everyday products and ensure the safety of replacements to protect maternal and child health.
Health Implications of Chemical Exposure During Pregnancy
Exposure to multiple environmental chemicals during pregnancy has been increasingly recognized as a significant risk factor for adverse health outcomes affecting both the mother and fetus. Research indicates that pregnant women in the United States are routinely exposed to a broad array of chemicals—including phthalates, replacement plasticizers, polycyclic aromatic hydrocarbons (PAHs), halogenated phenols, perfluoroalkyl substances (PFAS), and persistent organic pollutants—often at levels associated with negative developmental and health effects in children.
Prenatal exposure to these chemicals has been linked to a variety of pregnancy complications such as gestational diabetes and maternal hypertensive disorders, which can jeopardize maternal health and fetal development. Furthermore, the chemicals may disrupt the maternal microbiome, a factor implicated in poor perinatal outcomes including adverse fetal growth and preterm birth. The biological mechanisms underlying these effects involve direct chemical interactions with the placenta, causing tissue damage, inflammatory responses, and interference with microbial colonization critical for fetal health.
Adverse birth outcomes associated with chemical exposures during fetal development include preterm birth, low birth weight, and major congenital anomalies (MCAs), all of which contribute significantly to perinatal morbidity and mortality. MCAs such as circulatory, respiratory, digestive, genital, and chromosomal abnormalities have been shown to correlate strongly with preterm birth and low birth weight, exacerbating the risk of neonatal complications. Notably, these adverse outcomes are further influenced by social determinants such as socioeconomic status and race, with some studies reporting stronger effects among minority populations exposed to traffic-related air pollution and other environmental stressors.
Endocrine-disrupting chemicals (EDCs), which include substances like bisphenol A, phthalates, flame retardants, and PFAS, pose particular concern due to their ability to interfere with hormonal signaling and developmental processes during pregnancy. These disruptions have been linked to congenital abnormalities, fetal growth restriction, miscarriage, and neurodevelopmental deficits. Given their widespread presence in consumer products, food, and environmental media, exposure to EDCs is pervasive and often involves complex mixtures that may exert synergistic effects.
The cumulative impact of multiple chemical exposures during pregnancy may be greater than the sum of individual exposures, potentially potentiating adverse health outcomes. However, despite biomonitoring evidence demonstrating nearly ubiquitous exposure to numerous chemicals during critical periods of fetal development, the specific contributions of individual and combined chemical exposures to adverse outcomes remain poorly characterized, warranting further comprehensive exposure assessment and mechanistic research.
Epidemiological and Toxicological Evidence
Well-conducted epidemiological studies consistently demonstrate a relationship between exposure to certain environmental chemicals in pregnant women and adverse birth outcomes. These studies reveal trends linking changing levels of exposure to specific effects such as preterm birth, low birth weight, and congenital abnormalities. Animal studies further support these associations by showing biological correlations between chemical exposures and harmful developmental effects in offspring.
Prenatal exposure to multiple harmful chemicals, including polychlorinated biphenyls (PCBs), organochlorine pesticides (OCPs), perfluorinated compounds (PFCs), industrial phenols, and phthalates, has been linked to negative outcomes both at birth and later in life. At birth, these outcomes include preterm delivery, low birth weight, and birth defects, while long-term effects may manifest as neurodevelopmental deficits, cancer, and cardiovascular disease. Importantly, exposure to multiple chemicals simultaneously is thought to have a compounded impact greater than that of individual substances alone.
Phthalates, chemicals commonly found in personal care products and food packaging, have been associated with increased risk of preterm birth. Research indicates that exposure to certain phthalates during pregnancy raises the probability of preterm birth by 14-16%. Among these, di-(2-ethylhexyl) phthalate (DEHP) and diisononyl phthalate (DiNP) have been specifically studied due to their prevalence in areas with extensive plastics industries and plastic waste accumulation. However, existing studies highlight the need for further research, including meta-analyses, to generate more precise effect estimates and better understand their combined contribution to preterm birth and related morbidities.
Per- and polyfluoroalkyl substances (PFAS), often referred to as “forever chemicals,” have also been implicated in maternal and child health harms. Elevated PFAS levels in pregnant women’s blood, including compounds such as perfluorooctanesulfonic acid (PFOS), have been linked to pregnancy complications, preeclampsia, childhood obesity, developmental delays, preterm birth, and low birth weight. Studies of cord blood samples reinforce the pervasive exposure to PFAS and the potential threat to fetal development.
Organochlorine pesticides have been shown to affect fetal growth and contribute to congenital abnormalities, including neural tube defects and cleft palate. Residential proximity to agricultural pesticide application during pregnancy has been correlated with increased rates of preterm birth and low birth weight, highlighting environmental exposure as a significant risk factor.
Toxicological evidence demonstrates that mixtures of multiple chemicals, even at relatively low doses, can produce additive adverse effects. For example, animal studies have reported severe permanent birth defects following prenatal exposure to chemical mixtures acting through diverse molecular pathways. This underscores the complexity of evaluating combined chemical exposures and their developmental toxicity.
Given the limited control individuals have over environmental exposures during pregnancy, even small changes in birth weight or gestational age resulting from chemical exposure can have substantial impacts on children’s health outcomes. These findings suggest the importance of incorporating environmental exposure assessments into prenatal care and public health strategies. Moreover, the economic burden associated with phthalate-related preterm birth morbidity and cardiovascular mortality linked to chemical exposures is substantial, representing a significant societal cost often borne by governments and the public rather than the chemical industry itself.
Population Exposure and Geographic Scope
Exposure to multiple chemicals during pregnancy is widespread, with numerous studies demonstrating that pregnant women in various regions are exposed to a broad array of both banned and contemporary chemical contaminants. Data from the United States, for example, reveal ubiquitous exposure to numerous chemical analytes during critical periods of fetal development, raising concerns about potential adverse birth outcomes and long-term health effects in children and adults. Despite the prevalence of such exposures, further research is needed to identify dominant sources and inform policy measures aimed at reducing risks for this vulnerable population.
Geographically, the burden of chemical exposure and its associated health consequences is not uniformly distributed. Recent global analyses estimate that regions undergoing rapid industrialization and increased plastic use, particularly the Middle East and South Asia, bear more than half of the worldwide burden linked to exposure to phthalates such as DEHP. These findings align with evidence highlighting disproportionate rates of preterm birth (PTB) and related complications in these areas, where limited regulatory frameworks and growing plastics industries contribute to elevated exposure levels. Africa is also noted as a region experiencing a significant portion of the global PTB burden related to phthalate exposure.
The wide geographic variation in exposure underscores the need for targeted regulatory actions and public health interventions, especially in high-risk regions, to mitigate chemical risks to pregnant women and their developing fetuses. Additionally, socioeconomic factors and psychosocial stressors, which vary by location and population, can compound exposure risks and adverse birth outcomes, further emphasizing the complexity of addressing chemical exposures globally.
Regulatory and Public Health Responses
Addressing the widespread exposure of pregnant women to environmental chemicals has become a significant public health concern, as these exposures are linked to adverse birth outcomes including preterm birth, low birthweight, and developmental disorders. Despite the known risks, control over these exposures remains limited, highlighting the need for more effective regulatory and intervention strategies.
Currently, federal laws that regulate chemicals, such as those aiming to remove unsafe substances from commerce, face challenges in keeping pace with the extensive and varied chemical exposures pregnant women encounter[8
Future Directions
Recent research highlights the urgent need to expand our understanding of chemical exposures during pregnancy and their implications for birth outcomes such as preterm birth and low birth weight. Although medical causes of premature birth are well established, the influence of environmental chemical exposure remains less clear, necessitating further investigation.
A key priority for future studies is to examine the combined effects of simultaneous exposure to multiple chemicals, as mixtures can pose greater developmental and reproductive health risks than individual substances alone. This is particularly relevant given the widespread presence of numerous synthetic chemicals—such as phthalates, organochlorine pesticides, and perfluorinated compounds—in the environment and consumer products. The complexity of these exposures, including their sources and pathways during pregnancy, underscores the need for comprehensive biomonitoring and exposure assessment research to identify dominant contributors to maternal chemical burdens.
Moreover, interventions to reduce exposure at the population level show promise. Modeling studies suggest that even modest reductions in phthalate metabolite levels could prevent a significant proportion of preterm births, emphasizing the potential benefits of behavioral changes, voluntary corporate actions, and strengthened regulatory standards targeting entire classes of harmful chemicals rather than single compounds. Such strategies align with recommendations from authoritative bodies like the National Academies of Sciences, Engineering, and Medicine to implement broader chemical regulations.
Public health efforts must also address the challenge of communicating risks without causing undue anxiety among pregnant women, reinforcing that exposure is largely beyond individual control and focusing on achievable actions to mitigate risk. Finally, continued support for large-scale programs, such as the Environmental influences on Child Health Outcomes (ECHO) initiative, will be essential to drive multidisciplinary research, inform policy decisions, and ultimately reduce the burden of environmentally linked birth complications.
The content is provided by Sierra Knightley, Lifelong Health Tips
